43 related articles for article (PubMed ID: 3493116)
1. Transcription expressed by isolated cell nuclei in relation to the cell cycle.
Wojcierowski J; Antosz H; Orlicz-Welcz B
Cytobios; 1987; 49(196):7-16. PubMed ID: 3493116
[TBL] [Abstract][Full Text] [Related]
2. Expression of c-fos and c-jun proteins and AP-1 binding activity during cell cycle progression of HL60 cells and phytohemagglutinin-stimulated lymphocytes.
Tay DL; Hoffbrand AV; Wickremasinghe GR
Exp Hematol; 1996 Feb; 24(2):277-84. PubMed ID: 8641353
[TBL] [Abstract][Full Text] [Related]
3. Rapamycin inhibits ribosomal protein synthesis and induces G1 prolongation in mitogen-activated T lymphocytes.
Terada N; Takase K; Papst P; Nairn AC; Gelfand EW
J Immunol; 1995 Oct; 155(7):3418-26. PubMed ID: 7561036
[TBL] [Abstract][Full Text] [Related]
4. Glucocorticoids reversibly arrest rat hepatoma cell growth by inducing an early G1 block in cell cycle progression.
Sánchez I; Goya L; Vallerga AK; Firestone GL
Cell Growth Differ; 1993 Mar; 4(3):215-25. PubMed ID: 8466859
[TBL] [Abstract][Full Text] [Related]
5. Cell cycle progression out of G1 sensitizes primary-cultured nontransformed T cells to TCR-mediated apoptosis.
Radvanyi LG; Shi Y; Mills GB; Miller RG
Cell Immunol; 1996 Jun; 170(2):260-73. PubMed ID: 8660826
[TBL] [Abstract][Full Text] [Related]
6. Specific resistance of T cells to CD95-induced apoptosis during S phase of the cell cycle.
Dao T; Huleatt JW; Hingorani R; Crispe IN
J Immunol; 1997 Nov; 159(9):4261-7. PubMed ID: 9379021
[TBL] [Abstract][Full Text] [Related]
7. Rapamycin blocks cell cycle progression of activated T cells prior to events characteristic of the middle to late G1 phase of the cycle.
Terada N; Lucas JJ; Szepesi A; Franklin RA; Domenico J; Gelfand EW
J Cell Physiol; 1993 Jan; 154(1):7-15. PubMed ID: 8419408
[TBL] [Abstract][Full Text] [Related]
8. High levels of the onco-protein Gfi-1 accelerate T-cell proliferation and inhibit activation induced T-cell death in Jurkat T-cells.
Karsunky H; Mende I; Schmidt T; Möröy T
Oncogene; 2002 Feb; 21(10):1571-9. PubMed ID: 11896586
[TBL] [Abstract][Full Text] [Related]
9. Quantitative and qualitative signals determine T-cell cycle entry and progression.
Modiano JF; Mayor J; Ball C; Chitko-McKown CG; Sakata N; Domenico-Hahn J; Lucas JJ; Gelfand EW
Cell Immunol; 1999 Oct; 197(1):19-29. PubMed ID: 10555992
[TBL] [Abstract][Full Text] [Related]
10. Regulation of nuclear Prointerleukin-16 and p27(Kip1) in primary human T lymphocytes.
Wilson KC; Cattel DJ; Wan Z; Rahangdale S; Ren F; Kornfeld H; Sullivan BA; Cruikshank WW; Center DM
Cell Immunol; 2005 Sep; 237(1):17-27. PubMed ID: 16289056
[TBL] [Abstract][Full Text] [Related]
11. Effect of transforming growth factor-beta on early and late activation events in human T cells.
Ahuja SS; Paliogianni F; Yamada H; Balow JE; Boumpas DT
J Immunol; 1993 Apr; 150(8 Pt 1):3109-18. PubMed ID: 8468460
[TBL] [Abstract][Full Text] [Related]
12. HiNF-D (CDP-cut/CDC2/cyclin A/pRB-complex) influences the timing of IRF-2-dependent cell cycle activation of human histone H4 gene transcription at the G1/S phase transition.
Aziz F; van Wijnen AJ; Stein JL; Stein GS
J Cell Physiol; 1998 Dec; 177(3):453-64. PubMed ID: 9808153
[TBL] [Abstract][Full Text] [Related]
13. Method of double labelling applied to studies of transcription in isolated rat liver nuclei.
Wojcierowski J; Grzegórski S
Cytobios; 1986; 48(193):97-109. PubMed ID: 2431837
[TBL] [Abstract][Full Text] [Related]
14. Regulation of cAMP-responsive enhancer binding proteins during cell cycle progression in T lymphocytes stimulated by IL-2.
Feuerstein N; Huang D; Hinrichs SH; Orten DJ; Aiyar N; Prystowsky MB
J Immunol; 1995 Jan; 154(1):68-79. PubMed ID: 7995960
[TBL] [Abstract][Full Text] [Related]
15. Interleukin-2 expression in human carcinoma cell lines and its role in cell cycle progression.
Reichert TE; Nagashima S; Kashii Y; Stanson J; Gao G; Dou QP; Whiteside TL
Oncogene; 2000 Jan; 19(4):514-25. PubMed ID: 10698521
[TBL] [Abstract][Full Text] [Related]
16. An Escherichia coli RNA polymerase defective in transcription due to its overproduction of abortive initiation products.
Jin DJ; Turnbough CL
J Mol Biol; 1994 Feb; 236(1):72-80. PubMed ID: 7508986
[TBL] [Abstract][Full Text] [Related]
17. Different expression profiles of human cyclin B1 in normal PHA-stimulated T lymphocytes and leukemic T cells.
Viallard JF; Lacombe F; Dupouy M; Ferry H; Belloc F; Reiffers J
Cytometry; 2000 Feb; 39(2):117-25. PubMed ID: 10679729
[TBL] [Abstract][Full Text] [Related]
18. [Activation of the ribosomal gene during blast transformation of human lymphocytes].
Kalousek I; Hlavácová M; Röselová P; Otevrelová P
Cas Lek Cesk; 2002 Sep; 141 Suppl():54-7. PubMed ID: 12428425
[TBL] [Abstract][Full Text] [Related]
19. Cell cycle duration at the time of maternal zygotic transition for in vitro produced bovine embryos: effect of oxygen tension and transcription inhibition.
Lequarre AS; Marchandise J; Moreau B; Massip A; Donnay I
Biol Reprod; 2003 Nov; 69(5):1707-13. PubMed ID: 12890737
[TBL] [Abstract][Full Text] [Related]
20. Deoxyadenosine (AdR) inhibition of newly activated lymphocytes: blockade at the G0-G1 interface.
Redelman D; Bluestein HG; Cohen AH; Depper JM; Wormsley S
J Immunol; 1984 Apr; 132(4):2030-8. PubMed ID: 6421932
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
